Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Signaling in leukemia: which messenger to kill?

× No keyword cloud information.

16 in total

Review 1. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors: B J Druker; N B Lydon
Journal: J Clin Invest Date: 2000-01 Impact factor: 14.808

2. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.

Authors: M Carroll; M H Tomasson; G F Barker; T R Golub; D G Gilliland
Journal: Proc Natl Acad Sci U S A Date: 1996-12-10 Impact factor: 11.205

3. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.

Authors: M H Tomasson; D W Sternberg; I R Williams; M Carroll; D Cain; J C Aster; R L Ilaria; R A Van Etten; D G Gilliland
Journal: J Clin Invest Date: 2000-02 Impact factor: 14.808

4. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

Authors: A Goga; J McLaughlin; D E Afar; D C Saffran; O N Witte
Journal: Cell Date: 1995-09-22 Impact factor: 41.582

5. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes.

Authors: D Fambrough; K McClure; A Kazlauskas; E S Lander
Journal: Cell Date: 1999-06-11 Impact factor: 41.582

6. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase.

Authors: R P Million; R A Van Etten
Journal: Blood Date: 2000-07-15 Impact factor: 22.113

Review 7. Chromosomal translocations in human cancer.

Authors: T H Rabbitts
Journal: Nature Date: 1994-11-10 Impact factor: 49.962

8. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.

Authors: A M Pendergast; L A Quilliam; L D Cripe; C H Bassing; Z Dai; N Li; A Batzer; K M Rabun; C J Der; J Schlessinger
Journal: Cell Date: 1993-10-08 Impact factor: 41.582

Review 9. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia.

Authors: J W Wessels; W E Fibbe; D van der Keur; J E Landegent; D C van der Plas; G J den Ottolander; K J Roozendaal; G C Beverstock
Journal: Cancer Genet Cytogenet Date: 1993-01

10. Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.

Authors: A K Arvidsson; E Rupp; E Nånberg; J Downward; L Rönnstrand; S Wennström; J Schlessinger; C H Heldin; L Claesson-Welsh
Journal: Mol Cell Biol Date: 1994-10 Impact factor: 4.272

1 in total

1. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.

Authors: J C Aster; L Xu; F G Karnell; V Patriub; J C Pui; W S Pear
Journal: Mol Cell Biol Date: 2000-10 Impact factor: 4.272

1 in total